Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 10.

Gollins, Simon, West, Nicholas, Sebag-Montefiore, David, Susnerwala, Shabbir, Falk, Stephen, Brown, Nick, Saunders, Mark, Quirke, Philip, Ray, Ruby, Parsons, Philip, Griffiths, Gareth, Maughan, Tim, Adams, Richard and Hurt, Christopher 2018. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British Journal of Cancer 10.1038/s41416-018-0209-4
file

Crosby, Tom, Hurt, Christopher, Falk, S, Gollins, S, Staffurth, John, Ray, Ruby, Bridgewater, J A, Geh, J I, Cunningham, D, Blazeby, J, Roy, R, Maughan, Timothy, Griffiths, Gwyn and Mukherjee, Saptarshi 2017. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/? cetuximab in oesophageal cancer. British Journal of Cancer 116 (6) , pp. 709-716. 10.1038/bjc.2017.21
file

Mukherjee, Somnath, Hurt, Christopher Nicholas, Gwynne, Sarah, Sebag-Montefiore, David, Radhakrishna, Ganesh, Gollins, Simon, Hawkins, Maria, Grabsch, Heike I., Jones, Gareth, Falk, Stephen, Sharma, Ricky, Bateman, Andrew, Roy, Rajarshi, Ray, Ruby, Canham, Joanna, Griffiths, Gareth, Maughan, Tim and Crosby, Tom 2017. NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer 74 , pp. 38-46. 10.1016/j.ejca.2016.11.031
file

Gwynne, Sarah, Jones, Gareth, Maggs, Rhydian, Eaton, David, Miles, Elizabeth, Staffurth, John, Nixon, Lisette, Ray, Ruby, Lewis, Geraint, Crosby, Thomas and Spezi, Emiliano 2016. Prospective review of radiotherapy trials through implementation of standardised multi-centre workflow and IT infrastructure. British Journal of Radiology 89 (1064) , 20160020. 10.1259/bjr.20160020
file

Rees, J., Hurt, Chris Nicholas, Gollins, S., Mukherjee, S., Maughan, Timothy, Falk, S. J., Staffurth, John Nicholas, Ray, Ruby, Bashir Mohamad, Nurul, Geh, J. I., Cunningham, D., Roy, R., Bridgewater, J., Griffiths, G., Nixon, Lisette Sheena, Blazeby, J. M. and Crosby, T. 2015. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. British Journal of Cancer 113 (4) , pp. 603-610. 10.1038/bjc.2015.258

Gollins, Simon, Sebag-Montefiore, David, Adams, Richard, Saunders, Mark P., Grieve, Robert, Scott, Nigel, Brown, Gina, Quirke, Philip, Butlin, Laura, Ray, Ruby, Griffiths, Gareth and Hurt, Chris Nicholas 2015. A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). Journal of Clinical Oncology 33 (15) , p. 3609.

Crosby, Thomas, Mukherjee, Somnath, Hurt, Chris Nicholas, Gwynne, Sarah, Gollins, Simon, Batrman, Andrew Rea, Lewis, Wyn Griffith, Radhakrishna, Ganesh, Hawkins, Maria, Grabsch, Heike I., Ray, Ruby, Sharma, Ricky A., Wade, Wendy, Maggs, Rhydian, Tranter, Bethan, Roberts, Ashley, Hadlow, Sue, Sebag-Montefiore, David, Maughan, Tim and Griffiths, Gareth 2014. NeoSCOPE: A phase II randomized comparison of neoadjuvant oxaliplatin/capecitabine versus carboplatin/paclitaxel-based chemoradiation in operable esophageal cancer [Abstract]. Journal of Clinical Oncology 32 (15_sup) , TPS4144. 10.1200/jco.2014.32.15_suppl.tps4144

Crosby, Thomas David Lewis, Hurt, Chris Nicholas, Falk, Stephen, Gollins, Simon, Mukherjee, Somnath, Staffurth, John Nicholas, Ray, Ruby, Bashir, Nadim, Bridgewater, John A., Geh, J. Ian, Cunningham, David, Blazeby, Jane, Roy, Rajarshi, Maughan, Timothy Stanley and Griffiths, Gareth O. 2013. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. The Lancet Oncology 14 (7) , pp. 627-637. 10.1016/S1470-2045(13)70136-0
file

Mukherjee, Somnath, Hurt, Chris Nicholas, Bridgewater, John, Falk, Stephen, Cummins, Sebastian, Wasan, Harpreet, Crosby, Thomas David Lewis, Jephcott, Catherine, Roy, Rajarshi, Radhakrishna, Ganesh, McDonald, Alec, Ray, Ruby, Joseph, George, Staffurth, John Nicholas, Abrams, Ross A., Griffiths, Gareth O. and Maughan, Timothy Stanley 2013. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. The Lancet Oncology 14 (4) , pp. 317-326. 10.1016/S1470-2045(13)70021-4
file

Crosby, T., Hurt, Chris Nicholas, Falk, S., Gollins, S., Mukherjee, Saptarshi, Staffurth, John Nicholas, Ray, Ruby, Bashir, N., Bridgwater, J., Geh, J. I., Cunningham, D., Blazeby, J., Roy, R., Maughan, T and Griffiths, Gareth 2013. SCOPE 1: A phase II/III trial of chemoradiotherapy in esophageal cancer plus or minus cetuximab. American Journal of Clinical Oncology 31 (Supp 4) , LBA3. 10.1200/jco.2013.31.4_suppl.lba3

This list was generated on Fri Sep 20 05:35:31 2019 BST.